Table 2 Medication at 36 months.

From: Nurse-led, telephone-based follow-up after acute coronary syndrome yields improved risk factors after 36 months: the randomized controlled NAILED-ACS trial

 

Control (n = 391), %

Intervention (n = 406), %

P

Statins

86.9

90

0.16

Diuretics

32.2

38.7

0.06

Beta-blockers

88.7

86.6

0.38

Angiotensin-converting enzyme inhibitors

47.4

44.4

0.39

Angiotensin receptor blockers

29.4

35.6

0.06

Calcium channel blockers

28.6

35.7

0.03

Aspirin

83.5

78.9

0.1

Other antiplatelet druga

8

8.2

0.92

Anticoagulants

9.8

13.9

0.07

  1. aOther antiplatelet drug, e.g., clopidogrel, ticagrelor.